Vertex Pharmaceuticals Incorporated (VX1)
Market Closed
10 Aug, 20:00
€
457. 70
+38.8
+9.2624%
€
- Market Cap
30.83 P/E Ratio
- Div Yield
106 Volume
14.94 Eps
€ 418.9
Previous Close Want to track VX1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vertex Pharmaceuticals Incorporated (VX1) Statistics
Valuation metrics
Market Cap -
Enterprise value 119.76B
Trailing P/E (ttm) 28.64
Forward P/E -
PEG ratio 1.27
Price/Sales (ttm) 9.97
Price/Book (mrq) 6.22
Enterprise Value/Revenue 9.49
Enterprise Value/EBITDA 22
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 247
Average volume (90 days) 68
Price summary
52-Week low 313.75
52-Week high 462.6
Beta -
50-Day moving average 424.46
200-Day moving average 396.59
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 24 Aug 2000
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.35%
Operating margin 0.39%
Operational effectiveness
Return on assets 0.16%
Return on equity 0.23%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 49.72
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 17.35
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 30.93
Total debt (mrq) -
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 3.19%
Book value per share (mrq) 79.75
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
